Breadcrumb Home investors intimation stock exchanges Intimation to stock Exchanges Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-20162014-20152013-20142012-20132011-20122010-2011 Apply GST order received from Office of the Joint Commissioner, Large Taxpayer Unit, Corporate Division, West Bengal 06th Mar 2024 Schedule of Analyst / Institutional Investor Meetings 05th Mar 2024 Update on transfer of Generics Business Undertaking of the Company to Cipla Pharma and Life Sciences Limited, wholly owned subsidiary 01st Mar 2024 Update on incorporation of a joint venture company in USA 01st Mar 2024 USFDA inspection at manufacturing facility in Qidong, Jiangsu Province, China 01st Mar 2024 Intimation for Loss of Share Certificates 01st Mar 2024 Allotment of 5,863 equity shares under ESOS 2013-A Scheme and Cipla ESAR Scheme 2021 of the Company 16th Feb 2024 Issuance of Duplicate Share Certificates 13th Feb 2024 Update on acquisition of Actor Pharma (Pty) Ltd., South Africa 07th Feb 2024 Update on acquisition of additional stake in GoApptiv Private Limited 02nd Feb 2024 Pagination First page first Previous page ‹ Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Next page › Last page last BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.